Ko Igami

Title: Innovations by Ko Igami

Introduction

Ko Igami is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of conditions related to blood disorders. With a total of two patents to his name, his work has the potential to impact patient care significantly.

Latest Patents

Ko Igami's latest patents include a method and kit for detecting conditions in patients with disturbances of consciousness. This innovative method analyzes the amount and/or activity of a von Willebrand factor-cleaving protease. The kit is designed to detect conditions such as cerebrovascular disease and arteriosclerotic vascular disease, as well as predict severity. His second patent focuses on determining appropriate treatment options for patients diagnosed with disseminated intravascular coagulation (DIC). This method involves analyzing the amount and enzyme activity of a von Willebrand factor-cleaving protease (ADAMTS13) and the amount of von Willebrand factor in patients diagnosed with DIC. This innovation allows for a differential diagnosis between DIC and thrombotic thrombocytopenic purpura (TTP), which was previously challenging.

Career Highlights

Throughout his career, Ko Igami has worked with prominent companies such as LSI Medience Corporation and Mitsubishi Chemical Medience Corporation. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.

Collaborations

Ko Igami has collaborated with notable colleagues, including Tomoko Ono and Fumio Furusaki. These collaborations have likely enriched his research and development efforts in the medical field.

Conclusion

Ko Igami's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving patient care. His work in detecting and treating blood disorders is paving the way for advancements in medical technology.